Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter.

Ghersa P, Whelan J, Cambet Y, DeLamarter JF, Hooft van Huijsduijnen R.

Nucleic Acids Res. 1997 Jan 15;25(2):339-46.

2.

Commonly used cat reporter vectors contain a cAMP-inducible, cryptic enhancer that co-operates with NF-kappa B-sites.

Ghersa P, Whelan J, Pescini R, DeLamarter JF, Hooft van Huijsduijnen R.

Gene. 1994 Dec 30;151(1-2):331-2.

PMID:
7530226
3.

Transcription factor-induced, phased bending of the E-selectin promoter.

Meacock S, Pescini-Gobert R, DeLamarter JF, Hooft van Huijsduijnen R.

J Biol Chem. 1994 Dec 16;269(50):31756-62.

4.

Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway.

Ghersa P, Hooft van Huijsduijnen R, Whelan J, Cambet Y, Pescini R, DeLamarter JF.

J Biol Chem. 1994 Nov 18;269(46):29129-37.

6.

Inducible inhibition of eukaryotic gene expression.

Pescini R, Alouani S, Proudfoot A, Power C, Mermod JJ, DeLamarter JF, Hooft van Huijsduijnen R.

Biochem Biophys Res Commun. 1994 Aug 15;202(3):1664-7.

PMID:
8060354
7.

RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers.

Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF, Becker-André M.

Mol Endocrinol. 1994 Jun;8(6):757-70.

PMID:
7935491
8.

Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells.

Calenda V, Graber P, Delamarter JF, Chermann JC.

Eur J Haematol. 1994 Feb;52(2):103-7.

PMID:
8119379
9.

ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers.

Pescini R, Kaszubska W, Whelan J, DeLamarter JF, Hooft van Huijsduijnen R.

J Biol Chem. 1994 Jan 14;269(2):1159-65.

10.

Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines.

Kaszubska W, Hooft van Huijsduijnen R, Ghersa P, DeRaemy-Schenk AM, Chen BP, Hai T, DeLamarter JF, Whelan J.

Mol Cell Biol. 1993 Nov;13(11):7180-90.

11.

Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences.

Becker-André M, André E, DeLamarter JF.

Biochem Biophys Res Commun. 1993 Aug 16;194(3):1371-9.

PMID:
7916608
12.

Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element.

Hooft van Huijsduijnen R, Pescini R, DeLamarter JF.

Nucleic Acids Res. 1993 Aug 11;21(16):3711-7.

13.

DNA-methylation of the E-selectin promoter represses NF-kappa B transactivation.

Smith GM, Whelan J, Pescini R, Ghersa P, DeLamarter JF, Hooft van Huijsduijnen R.

Biochem Biophys Res Commun. 1993 Jul 15;194(1):215-21.

PMID:
7687427
14.

A T-cell enhancer cooperates with NF-kappa B to yield cytokine induction of E-selectin gene transcription in endothelial cells.

Hooft van Huijsduijnen R, Whelan J, Pescini R, Becker-André M, Schenk AM, DeLamarter JF.

J Biol Chem. 1992 Nov 5;267(31):22385-91.

15.

Labile proteins play a dual role in the control of endothelial leukocyte adhesion molecule-1 (ELAM-1) gene regulation.

Ghersa P, Hooft van Huijsduijnen R, Whelan J, DeLamarter JF.

J Biol Chem. 1992 Sep 25;267(27):19226-32.

16.

Murine endothelial leukocyte-adhesion molecule 1 is a close structural and functional homologue of the human protein.

Becker-André M, Hooft van Huijsduijnen R, Losberger C, Whelan J, Delamarter JF.

Eur J Biochem. 1992 Jun 1;206(2):401-11.

17.

A means to reduce the complexity of oligonucleotides encoding degenerate peptides.

Hooft van Huijsduijnen RA, Ayala G, DeLamarter JF.

Nucleic Acids Res. 1992 Feb 25;20(4):919. No abstract available.

18.

An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription.

Whelan J, Ghersa P, Hooft van Huijsduijnen R, Gray J, Chandra G, Talabot F, DeLamarter JF.

Nucleic Acids Res. 1991 May 25;19(10):2645-53.

19.

Rates of mutation to growth factor autonomy and tumorigenicity differ in hematopoietic stem and precursor cells expressing the multilineage colony-stimulating factor gene.

Laker C, Kluge N, Stocking C, Just U, Franz MJ, Ostertag W, DeLamarter JF, Dexter M, Spooncer E.

Mol Cell Biol. 1989 Dec;9(12):5746-9.

20.

Infection of multipotent IL-3-dependent stem cells with a retroviral vector containing the IL-3 gene confers density-dependent growth autonomy without blocking differentiation.

Just U, Spooncer E, Katsuno M, Hampson I, Dexter M, DeLamarter JF, Stocking C, Kluge N, Ostertag W.

Haematol Blood Transfus. 1989;32:197-205. No abstract available.

PMID:
2483147
21.

Hemopoietic colony stimulating factors. A physiological and pharmacological role in fighting infection?

DeLamarter JF.

Biochem Pharmacol. 1988 Aug 15;37(16):3057-62. Review. No abstract available.

PMID:
2456765
22.

The effect of stem cell proliferation regulators demonstrated with an in vitro assay.

Pragnell IB, Wright EG, Lorimore SA, Adam J, Rosendaal M, DeLamarter JF, Freshney M, Eckmann L, Sproul A, Wilkie N.

Blood. 1988 Jul;72(1):196-201.

PMID:
3291981
23.

Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells.

Moonen P, Mermod JJ, Ernst JF, Hirschi M, DeLamarter JF.

Proc Natl Acad Sci U S A. 1987 Jul;84(13):4428-31.

24.

Nucleotide sequence of a cDNA encoding murine CSF-1 (Macrophage-CSF).

DeLamarter JF, Hession C, Semon D, Gough NM, Rothenbuhler R, Mermod JJ.

Nucleic Acids Res. 1987 Mar 11;15(5):2389-90. No abstract available.

25.

Molecular cloning and production in microorganisms of hemopoietic growth factors.

Delamarter JF, Mermod JJ, Johnson MJ, Buell GN, Shaw A, Gough NM.

Ann N Y Acad Sci. 1987;511:50-64. No abstract available.

PMID:
3326478
26.

Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor.

Burgess AW, Begley CG, Johnson GR, Lopez AF, Williamson DJ, Mermod JJ, Simpson RJ, Schmitz A, DeLamarter JF.

Blood. 1987 Jan;69(1):43-51.

PMID:
3024761
27.

Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum.

DeLamarter JF, Mermod JJ, Liang CM, Eliason JF, Thatcher DR.

EMBO J. 1985 Oct;4(10):2575-81.

28.

Vasoactive intestinal peptide: expression of the prohormone in bacterial cells.

DeLamarter JF, Buell GN, Kawashima E, Polak JM, Bloom SR.

Peptides. 1985;6 Suppl 1:95-102.

PMID:
2995945
29.

The 28 S genomic RNA of avian sarcoma virus PRCII codes for the transformation-specific polyprotein P105.

DeLamarter JF, Neil JC, Ghysdael J, Vogt PK.

Virology. 1981 Jul 30;112(2):757-61. No abstract available.

PMID:
6266150
30.
31.

Transcriptional control of endogenous virus genes in murine lymphocytes.

DeLamarter JF, Monckton RP, Moroni C.

J Gen Virol. 1981 Feb;52(Pt 2):371-5.

PMID:
7288399
32.

Concanavalin A promotes bromodeoxyuridine induction of enodgenous C-Type virus in B cells.

Moroni C, Matter A, Stoye JP, Monckton RP, Delamarter JF, Schumann G.

Cell Immunol. 1980 Aug 15;54(1):107-14. No abstract available.

PMID:
6250728
33.

Normal B-cell activation involves endogenous retroviral antigen expression: implications for leukemogenesis.

Moroni C, Stoye JP, DeLamarter JF, Erb P, Jay FA, Jongstra J, Martin D, Schumann G.

Cold Spring Harb Symp Quant Biol. 1980;44 Pt 2,:1205-10. No abstract available.

PMID:
6968658
34.

Evidence supporting a physiological role for endogenous C-type virus in the immune system.

DeLamarter JF, Stoye J, Schumann G, Moroni C.

Haematol Blood Transfus. 1979;23:413-5. No abstract available.

PMID:
232464

Supplemental Content

Loading ...
Support Center